Related Experiment Video
Updated: Mar 31, 2026

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Melatonin as an adjuvant therapy in gestational hypertension and pre-eclampsia: A randomized controlled trial
Akanksha Lamba Thora1, Pankhudi Singh Jyoti1, Anupama Dave2
1Department of Obstetrics and Gynaecology, MTH Hospital, Indore Madhya Pradesh, India.
None:
In spite of the improvement of obstetric care, hypertensive disorders of pregnancy have continued to emerge as the major causes of maternal and perinatal morbidity. Therefore, it is of interest to assess the effectiveness of melatonin as an adjuvant treatment in the management of gestational hypertension and pre-eclampsia in 404 pregnant women (183 taking melatonin and 221 taking standard care) in one of the tertiary care hospitals in India. Melatonin group also showed much lower incidences of serious pre-eclampsia that necessitated cesarean section (2.73% vs 8.60, p=0.014), lower rate of proteinuria (28.42 vs 37.10), and a better fetal outcome with a lower incidence of intrauterine death (4.92 vs 9.50). Melatonin supplementation is a potential adjuvant treatment that is promising to decrease the maternal and infant complications in pregnancy-related hypertension disorders.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Hormonal Regulation
Hypertension V: Nursing Management

